Haleon plc
A British multinational consumer healthcare company offering a wide range of over-the-counter medicines, vitamins, and oral hygiene products globally.
About
Haleon plc is a global leader in consumer healthcare, formed as a spin-off from GSK in 2022. The company develops, manufactures, and sells a diverse portfolio of well-known brands, including Sensodyne, Panadol, Advil, and Centrum, across categories such as oral health, pain relief, and vitamins. Haleon aims to deliver better everyday health with humanity to consumers worldwide.
Listed competitors
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Pharmaceuticals, HealthTech
Global e-commerce, cloud computing, digital streaming, and artificial intelligence giant.
Shares Consumer Goods
Physics-based software platform for molecular discovery and design in life and materials sciences.
Shares Pharmaceuticals
Develops a computational model of the human body for drug discovery and development.
Shares Pharmaceuticals, HealthTech
Biotechnology company focused on developing cancer immunotherapies.
Shares Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Pharmaceuticals
Key facts
At-a-glance profile data
- Website
- haleon.com
- Headquarters
- Weybridge, United Kingdom
- Founded
- 2022
- Total funding
- -
- Business model
- B2C
Tech stack
Detected on haleon.com, last scanned 22 Sept 2026. Run your own scan
- Auth
- Okta
- Email provider
- Mimecast
- Hiring platform
- Eightfold
Frequently asked
Is Haleon plc trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Haleon plc is 26 out of 100, based on site security posture and privacy practices.